Document is current
Any future updates will be listed below
-
Authors
Khachigian, Levon M. https://orcid.org/0000-0003-3446-0323
Liew, Gerald
Teo, Kelvin Y. C.
Wong, Tien Y.
Mitchell, Paul
- License Information
-
More Information
Article History
Received: 1 November 2022
Accepted: 27 January 2023
First Online: 21 February 2023
Declarations
:
: Not applicable.
: Not applicable.
: LMK has IP interests in BT2. GL has consulted for Bayer and Novartis and has received travel grants and research funding from Bayer. KYCT reports consultancy fees, honorarium, travel support and speaker fees from Topcon, Roche, Bayer and Novartis outside the submitted work. TYW is a consultant for Bayer, Boehringer-Ingelheim, Eden Ophthalmic, Genentech, Iveric Bio, Merck, Novartis, Oxurion, Roche, Samsung, Shanghai Henlius and Zhaoke Pharmaceutical. He is an inventor, holds patents and is a co-founder of start-up companies (Plano and EyRiS), which have interests in, and develop digital solutions for eye diseases. All potential conflicts of interests for consultancy, advisory boards and positions in the start-up companies, and financial renumeration, if any, are managed by institutional policies under SingHealth and Duke-NUS Medical School. PM has consulted for Bayer, Novartis, and Allergan.
